NM_001039958.2:c.30C>T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_StrongBP6_ModerateBP7
The NM_001039958.2(MESP2):c.30C>T(p.Leu10Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000725 in 1,380,092 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_001039958.2 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MESP2 | NM_001039958.2 | c.30C>T | p.Leu10Leu | synonymous_variant | Exon 1 of 2 | ENST00000341735.5 | NP_001035047.1 | |
LOC124903550 | XR_007064751.1 | n.223G>A | non_coding_transcript_exon_variant | Exon 1 of 2 | ||||
LOC124903550 | XR_007064752.1 | n.188G>A | non_coding_transcript_exon_variant | Exon 1 of 2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MESP2 | ENST00000341735.5 | c.30C>T | p.Leu10Leu | synonymous_variant | Exon 1 of 2 | 1 | NM_001039958.2 | ENSP00000342392.3 | ||
MESP2 | ENST00000560219.2 | c.31-1678C>T | intron_variant | Intron 2 of 2 | 1 | ENSP00000452998.1 | ||||
MESP2 | ENST00000558723.1 | n.39-1678C>T | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 7.25e-7 AC: 1AN: 1380092Hom.: 0 Cov.: 31 AF XY: 0.00000147 AC XY: 1AN XY: 681198
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.